"TRIMing" the patient population to increase the benefit of mTOR inhibition.
Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI.
H Ian
HI
Robins
Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI.
Mark E
ME
Burkard
Affiliations of authors: Division of Hematology and Oncology (HIR, MEB) and Division of Gastroenterology and Hepatology (RBH), Department of Medicine, University of Wisconsin, Madison, WI. rbhalberg@medicine.wisc.edu.
Richard B
RB
Halberg
D000818:Animals; D002352:Carrier Proteins / Q000235:genetics*; D005260:Female; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D000070584:Tripartite Motif Proteins
D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; C540677:TRIM44 protein, human; D000070584:Tripartite Motif Proteins